Applied Therapeutics
Applied Therapeutics Soars Over 100% on Breakthrough CMT-SORD Trial and Renewed Investor Confidence
New York, NY – September 26, 2025 – Applied Therapeutics, Inc. (NASDAQ: APLT) ignited the biotech sector today, witnessing an astonishing stock surge of 103.50%. The dramatic leap comes on the heels of pivotal advancements for its lead drug candidate, govorestat (AT-007), targeting Charcot-Marie-Tooth Type 1A with Sorbitol Dehydrogenase (CMT-SORD) deficiency,